메뉴 건너뛰기




Volumn 17, Issue 33, 2011, Pages 3699-3712

Evaluation of the possible contribution of antioxidants administration in metabolic syndrome

Author keywords

Antioxidants; Cardiovascular disease; Insulin resistance; Metabolic syndrome; Oxidative stress; Reactive oxygen species

Indexed keywords

ADIPONECTIN; ALPHA TOCOPHEROL; ANGIOTENSIN II; ANTIOXIDANT; ASCORBIC ACID; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; CHROMIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE SYNTHASE; OMEGA 3 FATTY ACID; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; URSODEOXYCHOLIC ACID; VERY LOW DENSITY LIPOPROTEIN; VON WILLEBRAND FACTOR; ZINC;

EID: 82055206628     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798220882     Document Type: Article
Times cited : (20)

References (220)
  • 2
    • 29244482288 scopus 로고    scopus 로고
    • Definition of the metabolic syndrome: Current proposals and controversies
    • Reisin E, Alpert MA. Definition of the metabolic syndrome: current proposals and controversies. American J the Medical Sciences 2005; 330: 269-72.
    • (2005) American J the Medical Sciences , vol.330 , pp. 269-272
    • Reisin, E.1    Alpert, M.A.2
  • 3
    • 0000939795 scopus 로고
    • Studien uber das Hypertonie-Hyperglyka 'mie- Hyperurika' miesyndrom
    • Kylin E. Studien uber das Hypertonie-Hyperglyka 'mie- Hyperurika' miesyndrom. Zentralbl Inn Med 1923; 44: 105-27.
    • (1923) Zentralbl Inn Med , vol.44 , pp. 105-127
    • Kylin, E.1
  • 4
    • 0001217241 scopus 로고
    • Sexual differentiation, A factor affecting the forms of obesity
    • Vague J. Sexual differentiation, A factor affecting the forms of obesity. Presse Med 1947; 30: 339-40.
    • (1947) Presse Med , vol.30 , pp. 339-340
    • Vague, J.1
  • 5
    • 0023816690 scopus 로고
    • Role of insulin in regulation of lipoprotein metabolism in diabetes
    • Reaven GM, Chen YD. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes/Metabolism Reviews 1988; 4: 639-52.
    • (1988) Diabetes/Metabolism Reviews , vol.4 , pp. 639-652
    • Reaven, G.M.1    Chen, Y.D.2
  • 6
    • 0035856920 scopus 로고    scopus 로고
    • Global and societal implications of the diabetes epidemic
    • Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
    • (2001) Nature , vol.414 , pp. 782-787
    • Zimmet, P.1    Alberti, K.G.2    Shaw, J.3
  • 9
    • 0041866632 scopus 로고    scopus 로고
    • The insulin resistance syndrome and coronary artery disease
    • Kendall DM, Sobel BE, Coulston AM, et al. The insulin resistance syndrome and coronary artery disease. Coronary Artery Disease 2003; 14: 335-48.
    • (2003) Coronary Artery Disease , vol.14 , pp. 335-348
    • Kendall, D.M.1    Sobel, B.E.2    Coulston, A.M.3
  • 10
    • 10044279220 scopus 로고    scopus 로고
    • Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: The METSGREECE Multicentre Study
    • Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METSGREECE Multicentre Study. Current Medical Research and Opinion 2004; 20: 1691-1701.
    • (2004) Current Medical Research and Opinion , vol.20 , pp. 1691-1701
    • Athyros, V.G.1    Mikhailidis, D.P.2    Papageorgiou, A.A.3
  • 12
    • 0344946139 scopus 로고    scopus 로고
    • Recommendations for special populations: Diabetes mellitus and the metabolic syndrome
    • Sowers JR. Recommendations for special populations: diabetes mellitus and the metabolic syndrome. American J Hypertension 2003; 16: 41S-45S.
    • (2003) American J Hypertension , vol.16
    • Sowers, J.R.1
  • 14
    • 0037031088 scopus 로고    scopus 로고
    • Adiponectin and development of type 2 diabetes in the Pima Indian population
    • Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-8.
    • (2002) Lancet , vol.360 , pp. 57-58
    • Lindsay, R.S.1    Funahashi, T.2    Hanson, R.L.3
  • 15
    • 77954921980 scopus 로고    scopus 로고
    • Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome
    • Seet RC, Lee CY, Lim EC, et al. Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. Diabetes Care 2010; 33: 1140-2.
    • (2010) Diabetes Care , vol.33 , pp. 1140-1142
    • Seet, R.C.1    Lee, C.Y.2    Lim, E.C.3
  • 16
    • 10044263319 scopus 로고    scopus 로고
    • Adiponectin, obesity, and cardiovascular disease
    • Fasshauer M, Paschke R, Stumvoll M. Adiponectin, obesity, and cardiovascular disease. Biochimie 2004; 86: 779-84.
    • (2004) Biochimie , vol.86 , pp. 779-784
    • Fasshauer, M.1    Paschke, R.2    Stumvoll, M.3
  • 19
    • 0034891684 scopus 로고    scopus 로고
    • Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin
    • Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clinical Endocrinology & Metabolism 2001; 86: 3815-9.
    • (2001) J Clinical Endocrinology & Metabolism , vol.86 , pp. 3815-3819
    • Yang, W.S.1    Lee, W.J.2    Funahashi, T.3
  • 20
    • 0037540732 scopus 로고    scopus 로고
    • Resistin and adiponectin expression in visceral fat of obese rats: Effect of weight loss
    • Milan G, Granzotto M, Scarda A, et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obesity Research 2002; 10: 1095-103.
    • (2002) Obesity Research , vol.10 , pp. 1095-1103
    • Milan, G.1    Granzotto, M.2    Scarda, A.3
  • 21
    • 9144263120 scopus 로고    scopus 로고
    • A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity
    • Combs TP, Pajvani UB, Berg AH, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004; 145: 367-83.
    • (2004) Endocrinology , vol.145 , pp. 367-383
    • Combs, T.P.1    Pajvani, U.B.2    Berg, A.H.3
  • 22
    • 33744797675 scopus 로고    scopus 로고
    • Leptin: A promising therapeutic target with pleiotropic action besides body weight regulation
    • Paraskevas KI, Liapis CD, Mikhailidis DP. Leptin: a promising therapeutic target with pleiotropic action besides body weight regulation. Current Drug Targets 2006; 7: 761-71.
    • (2006) Current Drug Targets , vol.7 , pp. 761-771
    • Paraskevas, K.I.1    Liapis, C.D.2    Mikhailidis, D.P.3
  • 23
    • 17944365228 scopus 로고    scopus 로고
    • The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
    • Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Natural Medicines 2001; 7: 941-6.
    • (2001) Natural Medicines , vol.7 , pp. 941-946
    • Yamauchi, T.1    Kamon, J.2    Waki, H.3
  • 24
    • 0000454838 scopus 로고    scopus 로고
    • Insulin resistance: The fundamental trigger of type 2 diabetes
    • Groop LC. Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes, Obesity and Metabolism 1999; 1 Suppl 1: S1-7.
    • (1999) Diabetes, Obesity and Metabolism , vol.1 , Issue.SUPPL. 1
    • Groop, L.C.1
  • 26
    • 33645860825 scopus 로고    scopus 로고
    • Reactive oxygen species have a causal role in multiple forms of insulin resistance
    • Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-8.
    • (2006) Nature , vol.440 , pp. 944-948
    • Houstis, N.1    Rosen, E.D.2    Lander, E.S.3
  • 29
    • 33846516394 scopus 로고    scopus 로고
    • Small, dense low-density-lipoproteins and the metabolic syndrome
    • Rizzo M, Berneis K. Small, dense low-density-lipoproteins and the metabolic syndrome. Diabetes/Metabolism Research and Reviews 2007; 23: 14-20.
    • (2007) Diabetes/Metabolism Research and Reviews , vol.23 , pp. 14-20
    • Rizzo, M.1    Berneis, K.2
  • 30
    • 84910110212 scopus 로고    scopus 로고
    • The insulin resistance syndrome: Impact on lipoprotein metabolism and atherothrombosis
    • Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovascular Risk 2000; 7: 325-31.
    • (2000) J Cardiovascular Risk , vol.7 , pp. 325-331
    • Ginsberg, H.N.1    Huang, L.S.2
  • 31
    • 0037417237 scopus 로고    scopus 로고
    • Treatment for patients with the metabolic syndrome
    • Ginsberg HN. Treatment for patients with the metabolic syndrome. Amn J Cardiol 2003; 91: 29E-39E.
    • (2003) Amn J Cardiol , vol.91
    • Ginsberg, H.N.1
  • 33
    • 80051725784 scopus 로고    scopus 로고
    • "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
    • Mikhailidis DP, Elisaf M, Rizzo M, et al. "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses. Current Vascular Pharmacology 2011; 9: 533-71.
    • (2011) Current Vascular Pharmacology , vol.9 , pp. 533-571
    • Mikhailidis, D.P.1    Elisaf, M.2    Rizzo, M.3
  • 34
    • 80051769525 scopus 로고    scopus 로고
    • "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
    • Mikhailidis DP, Elisaf M, Rizzo M, et al. "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary. Current Vascular Pharmacology 2011; 9: 531-2.
    • (2011) Current Vascular Pharmacology , vol.9 , pp. 531-532
    • Mikhailidis, D.P.1    Elisaf, M.2    Rizzo, M.3
  • 35
  • 36
    • 0035254845 scopus 로고    scopus 로고
    • Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins
    • Tribble DL, Rizzo M, Chait A, Lewis DM, Blanche PJ, Krauss RM. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. American J Medicine 2001; 110: 103-10.
    • (2001) American J Medicine , vol.110 , pp. 103-110
    • Tribble, D.L.1    Rizzo, M.2    Chait, A.3    Lewis, D.M.4    Blanche, P.J.5    Krauss, R.M.6
  • 37
    • 34547859254 scopus 로고    scopus 로고
    • Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects
    • Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z, et al. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. European J Clinical Investigation 2007; 37: 715-23.
    • (2007) European J Clinical Investigation , vol.37 , pp. 715-723
    • Vekic, J.1    Kotur-Stevuljevic, J.2    Jelic-Ivanovic, Z.3
  • 38
    • 60749105826 scopus 로고    scopus 로고
    • High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles
    • Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, et al. High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis 2009; 203: 236-42.
    • (2009) Atherosclerosis , vol.203 , pp. 236-242
    • Vekic, J.1    Jelic-Ivanovic, Z.2    Spasojevic-Kalimanovska, V.3
  • 39
    • 0346363234 scopus 로고    scopus 로고
    • Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis
    • Kutuk O, Basaga H. Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis. Trends in Molecular Medicine 2003; 9: 549-57.
    • (2003) Trends in Molecular Medicine , vol.9 , pp. 549-557
    • Kutuk, O.1    Basaga, H.2
  • 40
    • 33745140143 scopus 로고    scopus 로고
    • Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria
    • Gazi I, Tsimihodimos V, Filippatos T, Bairaktari E, Tselepis AD, Elisaf M. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria. Metabolism: Clinical and Experimental 2006; 55: 885-91.
    • (2006) Metabolism: Clinical and Experimental , vol.55 , pp. 885-891
    • Gazi, I.1    Tsimihodimos, V.2    Filippatos, T.3    Bairaktari, E.4    Tselepis, A.D.5    Elisaf, M.6
  • 41
    • 37249058017 scopus 로고    scopus 로고
    • Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena
    • Gentile M, Panico S, Jossa F, Mattiello A, et al. Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena. Clinica Chimica Acta 2008; 388: 179-83.
    • (2008) Clinica Chimica Acta , vol.388 , pp. 179-183
    • Gentile, M.1    Panico, S.2    Jossa, F.3    Mattiello, A.4
  • 42
    • 35348843962 scopus 로고    scopus 로고
    • Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance
    • Julius U, Dittrich M, Pietzsch J. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance. International J Clinical Practice 2007; 61: 1798-804.
    • (2007) International J Clinical Practice , vol.61 , pp. 1798-1804
    • Julius, U.1    Dittrich, M.2    Pietzsch, J.3
  • 43
    • 27444443876 scopus 로고    scopus 로고
    • Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
    • (2005) Circulation , vol.112 , pp. 2735-2752
    • Grundy, S.M.1    Cleeman, J.I.2    Daniels, S.R.3
  • 44
    • 64349088492 scopus 로고    scopus 로고
    • Small, dense low-density lipoproteins (LDL) are predictors of cardio - and cerebro-vascular events in subjects with the metabolic syndrome
    • Rizzo M, Pernice V, Frasheri A, et al. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clinical Endocrinology 2009; 70: 870-5.
    • (2009) Clinical Endocrinology , vol.70 , pp. 870-875
    • Rizzo, M.1    Pernice, V.2    Frasheri, A.3
  • 45
    • 0036176783 scopus 로고    scopus 로고
    • Plasma free fatty acid levels and the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study
    • Pirro M, Mauriege P, Tchernof A, et al. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Atherosclerosis 2002; 160: 377-84.
    • (2002) Atherosclerosis , vol.160 , pp. 377-384
    • Pirro, M.1    Mauriege, P.2    Tchernof, A.3
  • 46
    • 0035954846 scopus 로고    scopus 로고
    • Postprandial dyslipidemia: An atherogenic disorder common in patients with diabetes mellitus
    • Ginsberg HN, Illingworth DR. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. American J Cardiology 2001; 88: 9H-15H.
    • (2001) American J Cardiology , vol.88
    • Ginsberg, H.N.1    Illingworth, D.R.2
  • 48
    • 0021367111 scopus 로고
    • In vivo stimulation of low-density lipoprotein degradation by insulin
    • Mazzone T, Foster D, Chait A. In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 1984; 33: 333-8.
    • (1984) Diabetes , vol.33 , pp. 333-338
    • Mazzone, T.1    Foster, D.2    Chait, A.3
  • 49
    • 0028858162 scopus 로고
    • Acute hyperinsulinemia decreases the hepatic secretion of very-lowdensity lipoprotein apolipoprotein B-100 in NIDDM
    • Cummings MH, Watts GF, Umpleby AM, et al. Acute hyperinsulinemia decreases the hepatic secretion of very-lowdensity lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 1995; 44: 1059-65.
    • (1995) Diabetes , vol.44 , pp. 1059-1065
    • Cummings, M.H.1    Watts, G.F.2    Umpleby, A.M.3
  • 52
    • 79955595080 scopus 로고    scopus 로고
    • Diagnostic value of postprandial triglyceride testing in healthy subjects: A metaanalysis
    • Mihas C, Kolovou GD, Mikhailidis DP, et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: a metaanalysis. Current Vascular Pharmacology 2011; 9: 271-80.
    • (2011) Current Vascular Pharmacology , vol.9 , pp. 271-280
    • Mihas, C.1    Kolovou, G.D.2    Mikhailidis, D.P.3
  • 53
    • 79955582390 scopus 로고    scopus 로고
    • Assessment and clinical relevance of non-fasting and postprandial triglycerides: An expert panel statement
    • Kolovou GD, Mikhailidis DP, Kovar J, et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Current Vascular Pharmacology 2011; 9: 258-70.
    • (2011) Current Vascular Pharmacology , vol.9 , pp. 258-270
    • Kolovou, G.D.1    Mikhailidis, D.P.2    Kovar, J.3
  • 54
    • 0034639491 scopus 로고    scopus 로고
    • Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study
    • Meigs JB, Mittleman MA, Nathan DM, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 2000; 283: 221-8.
    • (2000) JAMA , vol.283 , pp. 221-228
    • Meigs, J.B.1    Mittleman, M.A.2    Nathan, D.M.3
  • 56
    • 77957313606 scopus 로고    scopus 로고
    • Pathophysiology of the proatherothrombotic state in the metabolic syndrome
    • Palomo I, Moore-Carrasco R, Alarcon M, et al. Pathophysiology of the proatherothrombotic state in the metabolic syndrome. Front Biosci (Schol Ed) 2010; 2: 194-208.
    • (2010) Front Biosci (Schol Ed) , vol.2 , pp. 194-208
    • Palomo, I.1    Moore-Carrasco, R.2    Alarcon, M.3
  • 57
    • 0033860359 scopus 로고    scopus 로고
    • Insulin resistance and cardiovascular disease
    • Ginsberg HN. Insulin resistance and cardiovascular disease. J Clinical Investigation 2000; 106: 453-8.
    • (2000) J Clinical Investigation , vol.106 , pp. 453-458
    • Ginsberg, H.N.1
  • 58
    • 0036322988 scopus 로고    scopus 로고
    • Obesity, haemostasis and the fibrinolytic system
    • Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obesity Reviews 2002; 3: 85-101.
    • (2002) Obesity Reviews , vol.3 , pp. 85-101
    • Mertens, I.1    van Gaal, L.F.2
  • 60
    • 0031471127 scopus 로고    scopus 로고
    • Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells
    • Li XN, Grenett HE, Benza RL, et al. Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology 1997; 17: 3215-23.
    • (1997) Arteriosclerosis Thrombosis and Vascular Biology , vol.17 , pp. 3215-3223
    • Li, X.N.1    Grenett, H.E.2    Benza, R.L.3
  • 62
    • 0030893613 scopus 로고    scopus 로고
    • Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome
    • Velazquez EM, Mendoza SG, Wang P, Glueck CJ. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism: Clinical and Experimental 1997; 46: 454-7.
    • (1997) Metabolism: Clinical and Experimental , vol.46 , pp. 454-457
    • Velazquez, E.M.1    Mendoza, S.G.2    Wang, P.3    Glueck, C.J.4
  • 63
    • 50049125341 scopus 로고    scopus 로고
    • Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes
    • Correia S, Carvalho C, Santos MS, et al. Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Medicinal Chemistry 2008; 4: 358-64.
    • (2008) Medicinal Chemistry , vol.4 , pp. 358-364
    • Correia, S.1    Carvalho, C.2    Santos, M.S.3
  • 64
    • 58149330641 scopus 로고    scopus 로고
    • How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines
    • Ansari G, Mojtahedzadeh M, Kajbaf F, et al. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines. Advances in Therapy 2008; 25: 681-702.
    • (2008) Advances in Therapy , vol.25 , pp. 681-702
    • Ansari, G.1    Mojtahedzadeh, M.2    Kajbaf, F.3
  • 65
    • 0030975615 scopus 로고    scopus 로고
    • Production of plasminogen activator inhibitor 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease
    • Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860-7.
    • (1997) Diabetes , vol.46 , pp. 860-867
    • Alessi, M.C.1    Peiretti, F.2    Morange, P.3    Henry, M.4    Nalbone, G.5    Juhan-Vague, I.6
  • 66
    • 0033028415 scopus 로고    scopus 로고
    • Expression of plasminogen activator inhibitor-1 in human adipose tissue: A role for TNF-alpha?
    • Cigolini M, Tonoli M, Borgato L, et al. Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha? Atherosclerosis 1999; 143: 81-90.
    • (1999) Atherosclerosis , vol.143 , pp. 81-90
    • Cigolini, M.1    Tonoli, M.2    Borgato, L.3
  • 67
    • 0037408460 scopus 로고    scopus 로고
    • Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X
    • Lin CP, Lin WT, Leu HB, Wu TC, Chen JW. Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X. International J Cardiology 2003; 89: 53-62.
    • (2003) International J Cardiology , vol.89 , pp. 53-62
    • Lin, C.P.1    Lin, W.T.2    Leu, H.B.3    Wu, T.C.4    Chen, J.W.5
  • 69
    • 0032725206 scopus 로고    scopus 로고
    • Mechanisms of cellular activation by platelet microparticles
    • Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thrombosis and Haemostasis 1999; 82: 794-800.
    • (1999) Thrombosis and Haemostasis , vol.82 , pp. 794-800
    • Barry, O.P.1    Fitzgerald, G.A.2
  • 70
    • 2942517677 scopus 로고    scopus 로고
    • Role of tissue factor in hemostasis, thrombosis, and vascular development
    • Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arteriosclerosis Thrombosis and Vascular Biology 2004; 24: 1015-22.
    • (2004) Arteriosclerosis Thrombosis and Vascular Biology , vol.24 , pp. 1015-1022
    • Mackman, N.1
  • 71
    • 0141535106 scopus 로고    scopus 로고
    • Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy
    • Sajadi S, Ezekowitz MD, Dhond A, Netrebko P. Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy. Drug News and Perspectives 2003; 16: 363-9.
    • (2003) Drug News and Perspectives , vol.16 , pp. 363-369
    • Sajadi, S.1    Ezekowitz, M.D.2    Dhond, A.3    Netrebko, P.4
  • 72
    • 0034966562 scopus 로고    scopus 로고
    • Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers
    • Morange PE, Renucci JF, Charles MA, et al. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers. Thrombosis and Haemostasis 2001; 85: 999-1003.
    • (2001) Thrombosis and Haemostasis , vol.85 , pp. 999-1003
    • Morange, P.E.1    Renucci, J.F.2    Charles, M.A.3
  • 73
    • 0028903346 scopus 로고
    • Lipoproteins and thrombosis: Effects of lipid lowering
    • Miller GJ. Lipoproteins and thrombosis: effects of lipid lowering. Current Opinion in Lipidology 1995; 6: 38-42.
    • (1995) Current Opinion in Lipidology , vol.6 , pp. 38-42
    • Miller, G.J.1
  • 74
    • 3543065104 scopus 로고    scopus 로고
    • Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: The BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity
    • Charles MA, Morange P, Eschwege E, Andre P, Vague P, Juhan-Vague I. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity. Diabetes Care 1998; 21: 1967-72.
    • (1998) Diabetes Care , vol.21 , pp. 1967-1972
    • Charles, M.A.1    Morange, P.2    Eschwege, E.3    Andre, P.4    Vague, P.5    Juhan-Vague, I.6
  • 77
    • 0020670593 scopus 로고
    • Simulating the diabetic environment modifies in vitro prostacyclin synthesis
    • Jeremy JY, Mikhailidis DP, Dandona P. Simulating the diabetic environment modifies in vitro prostacyclin synthesis. Diabetes 1983; 32: 217-21.
    • (1983) Diabetes , vol.32 , pp. 217-221
    • Jeremy, J.Y.1    Mikhailidis, D.P.2    Dandona, P.3
  • 80
    • 0032936725 scopus 로고    scopus 로고
    • Evidence for a common antecedent?
    • Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance
    • Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care 1999; 22 Suppl 3: C25-30.
    • (1999) Diabetes Care , vol.22 , Issue.SUPPL. 3
  • 81
    • 1242330832 scopus 로고    scopus 로고
    • Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes
    • Haidara MA, Khloussy H, Ammar H, Aal Kassem LA. Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes. Med Sci Monit 2004; 10: BR41-6.
    • (2004) Med Sci Monit , vol.10
    • Haidara, M.A.1    Khloussy, H.2    Ammar, H.3    Aal Kassem, L.A.4
  • 82
    • 11344279659 scopus 로고    scopus 로고
    • C-reactive protein levels and outcomes after statin therapy
    • Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. New England J Medicine 2005; 352: 20-8.
    • (2005) New England J Medicine , vol.352 , pp. 20-28
    • Ridker, P.M.1    Cannon, C.P.2    Morrow, D.3
  • 83
    • 0142119459 scopus 로고    scopus 로고
    • Effects of statins on nonlipid serum markers associated with cardiovascular disease: A systematic review
    • Balk EM, Lau J, Goudas LC, et al. Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Annals of Internal Medicine 2003; 139: 670-82.
    • (2003) Annals of Internal Medicine , vol.139 , pp. 670-682
    • Balk, E.M.1    Lau, J.2    Goudas, L.C.3
  • 85
    • 77649180644 scopus 로고    scopus 로고
    • In vitro antioxidant activity of pravastatin provides vascular protection
    • Kassan M, Montero MJ, Sevilla MA. In vitro antioxidant activity of pravastatin provides vascular protection. European J Pharmacology 2010; 630: 107-11.
    • (2010) European J Pharmacology , vol.630 , pp. 107-111
    • Kassan, M.1    Montero, M.J.2    Sevilla, M.A.3
  • 87
    • 76149092815 scopus 로고    scopus 로고
    • Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome
    • Belfort R, Berria R, Cornell J, Cusi K. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome. J Clinical Endocrinology & Metabolism 2010; 95: 829-36.
    • (2010) J Clinical Endocrinology & Metabolism , vol.95 , pp. 829-836
    • Belfort, R.1    Berria, R.2    Cornell, J.3    Cusi, K.4
  • 91
    • 0030837996 scopus 로고    scopus 로고
    • High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
    • Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96: 25-8.
    • (1997) Circulation , vol.96 , pp. 25-28
    • Cosentino, F.1    Hishikawa, K.2    Katusic, Z.S.3    Luscher, T.F.4
  • 92
    • 58149166857 scopus 로고    scopus 로고
    • Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: Evidence of an oxidant-sensitive pathway
    • Desideri G, Grassi D, Croce G, Bocale R, Tiberti S, Evangelista S, Necozione S, Di Orio F, Ferri C. Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway. Mediators of Inflammation 2008; 2008: 305087.
    • (2008) Mediators of Inflammation , vol.2008 , pp. 305087
    • Desideri, G.1    Grassi, D.2    Croce, G.3    Bocale, R.4    Tiberti, S.5    Evangelista, S.6    Necozione, S.7    Di Orio, F.8    Ferri, C.9
  • 93
    • 82055173308 scopus 로고    scopus 로고
    • The mechanism underlying the development of hypertension in STZ-induced diabetic rats
    • Haidara MA, Desoky A, Khlousy H, Sebaee H. The mechanism underlying the development of hypertension in STZ-induced diabetic rats. Prog Med Res 2004; 2: 30.
    • (2004) Prog Med Res , vol.2 , pp. 30
    • Haidara, M.A.1    Desoky, A.2    Khlousy, H.3    Sebaee, H.4
  • 94
    • 0035991372 scopus 로고    scopus 로고
    • Antioxidant therapy potentiates antihypertensive action of insulin in diabetic rats
    • Koo JR, Ni Z, Oviesi F, Vaziri ND. Antioxidant therapy potentiates antihypertensive action of insulin in diabetic rats. Clinical and Experimental Hypertension 2002; 24: 333-44.
    • (2002) Clinical and Experimental Hypertension , vol.24 , pp. 333-344
    • Koo, J.R.1    Ni, Z.2    Oviesi, F.3    Vaziri, N.D.4
  • 95
    • 0030025673 scopus 로고    scopus 로고
    • Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system
    • Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. New England J Medicine 1996; 334: 374-81.
    • (1996) New England J Medicine , vol.334 , pp. 374-381
    • Reaven, G.M.1    Lithell, H.2    Landsberg, L.3
  • 96
    • 75749101030 scopus 로고    scopus 로고
    • Specific and pronounced impacts of lisinopril and lisinopril plus simvastatin on erythrocyte antioxidant enzymes
    • Kaminsky Y, Suslikov A, Kosenko E. Specific and pronounced impacts of lisinopril and lisinopril plus simvastatin on erythrocyte antioxidant enzymes. J Clinical Pharmacology 2010; 50: 180-7.
    • (2010) J Clinical Pharmacology , vol.50 , pp. 180-187
    • Kaminsky, Y.1    Suslikov, A.2    Kosenko, E.3
  • 97
    • 0043128821 scopus 로고    scopus 로고
    • Endothelial dysfunction: Clinical strategies for treating oxidant stress
    • Fenster BE, Tsao PS, Rockson SG. Endothelial dysfunction: clinical strategies for treating oxidant stress. American Heart Journal 2003; 146: 218-26.
    • (2003) American Heart Journal , vol.146 , pp. 218-226
    • Fenster, B.E.1    Tsao, P.S.2    Rockson, S.G.3
  • 98
    • 0035048905 scopus 로고    scopus 로고
    • Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis
    • Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37: 1047-52.
    • (2001) Hypertension , vol.37 , pp. 1047-1052
    • Dzau, V.J.1
  • 100
    • 4644310560 scopus 로고    scopus 로고
    • Role of oxidative modifications in atherosclerosis
    • Stocker R, Keaney JF, Jr. Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004; 84: 1381-478.
    • (2004) Physiological Reviews , vol.84 , pp. 1381-1478
    • Stocker, R.1    Keaney Jr., J.F.2
  • 101
    • 85030434746 scopus 로고    scopus 로고
    • Increased oxidative stress in obesity and its impact on metabolic syndrome
    • Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clinical Investigation 2004; 114: 1752-61.
    • (2004) J Clinical Investigation , vol.114 , pp. 1752-1761
    • Furukawa, S.1    Fujita, T.2    Shimabukuro, M.3
  • 102
    • 0031930768 scopus 로고    scopus 로고
    • Signal transduction in hepatic stellate cells
    • Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver 1998; 18: 2-13.
    • (1998) Liver , vol.18 , pp. 2-13
    • Pinzani, M.1    Marra, F.2    Carloni, V.3
  • 103
    • 0029073101 scopus 로고
    • Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration
    • Vendemiale G, Guerrieri F, Grattagliano I, Didonna D, Muolo L, Altomare E. Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration. Hepatology 1995; 21: 1450-4.
    • (1995) Hepatology , vol.21 , pp. 1450-1454
    • Vendemiale, G.1    Guerrieri, F.2    Grattagliano, I.3    Didonna, D.4    Muolo, L.5    Altomare, E.6
  • 105
    • 0033165758 scopus 로고    scopus 로고
    • Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery
    • Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J the American College of Cardiology 1999; 34: 146-54.
    • (1999) J the American College of Cardiology , vol.34 , pp. 146-154
    • Kawano, H.1    Motoyama, T.2    Hirashima, O.3
  • 106
    • 0035856980 scopus 로고    scopus 로고
    • Biochemistry and molecular cell biology of diabetic complications
    • Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
    • (2001) Nature , vol.414 , pp. 813-820
    • Brownlee, M.1
  • 107
    • 0025732948 scopus 로고
    • Role of oxidative stress in development of complications in diabetes
    • Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
    • (1991) Diabetes , vol.40 , pp. 405-412
    • Baynes, J.W.1
  • 108
    • 67649234171 scopus 로고    scopus 로고
    • A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: Common downstream endpoints achieved through disparate therapeutic approaches?
    • Sourris KC, Harcourt BE, Forbes JM. A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches? American J Nephrology 2009; 30: 323-35.
    • (2009) American J Nephrology , vol.30 , pp. 323-335
    • Sourris, K.C.1    Harcourt, B.E.2    Forbes, J.M.3
  • 109
    • 0035180299 scopus 로고    scopus 로고
    • Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site
    • Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clinical Investigation 2001; 108: 1341-8.
    • (2001) J Clinical Investigation , vol.108 , pp. 1341-1348
    • Du, X.L.1    Edelstein, D.2    Dimmeler, S.3    Ju, Q.4    Sui, C.5    Brownlee, M.6
  • 110
  • 111
    • 7944229937 scopus 로고    scopus 로고
    • Coenzyme Q10 and diabetic endotheliopathy: Oxidative stress and the 'recoupling hypothesis'
    • Chew GT, Watts GF. Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'. QJM 2004; 97: 537-48.
    • (2004) QJM , vol.97 , pp. 537-548
    • Chew, G.T.1    Watts, G.F.2
  • 112
    • 0035985081 scopus 로고    scopus 로고
    • Vascular function, insulin resistance and fatty acids
    • Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia 2002; 45: 623-34.
    • (2002) Diabetologia , vol.45 , pp. 623-634
    • Steinberg, H.O.1    Baron, A.D.2
  • 113
    • 0035923560 scopus 로고    scopus 로고
    • Homocysteine impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine
    • Stuhlinger MC, Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001; 104: 2569-75.
    • (2001) Circulation , vol.104 , pp. 2569-2575
    • Stuhlinger, M.C.1    Tsao, P.S.2    Her, J.H.3
  • 114
    • 4344666158 scopus 로고    scopus 로고
    • Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease
    • Diehl AM. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clinics in Liver Disease 2004; 8: 619-38, x.
    • (2004) Clinics in Liver Disease , vol.8
    • Diehl, A.M.1
  • 115
    • 13544258741 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis: Recent advances from experimental models to clinical management
    • Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clinical Biochemistry 2005; 38: 203-17.
    • (2005) Clinical Biochemistry , vol.38 , pp. 203-217
    • Portincasa, P.1    Grattagliano, I.2    Palmieri, V.O.3    Palasciano, G.4
  • 116
    • 4344628555 scopus 로고    scopus 로고
    • The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
    • McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clinics in Liver Disease 2004; 8: 521-33, viii.
    • (2004) Clinics in Liver Disease , vol.8
    • McCullough, A.J.1
  • 117
    • 24044536090 scopus 로고    scopus 로고
    • Recent concepts in non-alcoholic fatty liver disease
    • Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabetic Medicine 2005; 22: 1129-33.
    • (2005) Diabetic Medicine , vol.22 , pp. 1129-1133
    • Adams, L.A.1    Angulo, P.2
  • 118
    • 33846264060 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: The plot thickens
    • Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabetic Medicine 2007; 24: 1-6.
    • (2007) Diabetic Medicine , vol.24 , pp. 1-6
    • Targher, G.1
  • 119
    • 79959795387 scopus 로고    scopus 로고
    • NASH: A global health problem
    • Sanyal AJ. NASH: A global health problem. Hepatology Research 2011; 41: 670-4.
    • (2011) Hepatology Research , vol.41 , pp. 670-674
    • Sanyal, A.J.1
  • 120
    • 18244364864 scopus 로고    scopus 로고
    • NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
    • Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-9.
    • (2002) Hepatology , vol.35 , pp. 373-379
    • Chitturi, S.1    Abeygunasekera, S.2    Farrell, G.C.3
  • 123
    • 43649091349 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation
    • Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care 2008; 31: 587-9.
    • (2008) Diabetes Care , vol.31 , pp. 587-589
    • Ford, E.S.1    Li, C.2    Zhao, G.3    Pearson, W.S.4    Mokdad, A.H.5
  • 124
    • 0033625733 scopus 로고    scopus 로고
    • Insulin resistance influence iron metabolism and hepatic steatosis in type II diabetes
    • Vigano M, Vergani A, Trombini P, Paleari F, Piperno A. Insulin resistance influence iron metabolism and hepatic steatosis in type II diabetes. Gastroenterology 2000; 118: 986-7.
    • (2000) Gastroenterology , vol.118 , pp. 986-987
    • Vigano, M.1    Vergani, A.2    Trombini, P.3    Paleari, F.4    Piperno, A.5
  • 126
    • 0032171686 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
    • James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatology 1998; 29: 495-501.
    • (1998) J Hepatology , vol.29 , pp. 495-501
    • James, O.F.1    Day, C.P.2
  • 127
    • 78649890465 scopus 로고    scopus 로고
    • Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis
    • Athyros VG, Tziomalos K, Gossios TD, et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010; 376: 1916-22.
    • (2010) Lancet , vol.376 , pp. 1916-1922
    • Athyros, V.G.1    Tziomalos, K.2    Gossios, T.D.3
  • 128
    • 79953322846 scopus 로고    scopus 로고
    • Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients
    • Manousou P, Kalambokis G, Grillo F, et al. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver International 2011; 31: 730-9.
    • (2011) Liver International , vol.31 , pp. 730-739
    • Manousou, P.1    Kalambokis, G.2    Grillo, F.3
  • 129
    • 72049125105 scopus 로고    scopus 로고
    • Hepatitis C virus and nonalcoholic Fatty liver disease: Similar risk factors for necroinflammation, fibrosis, and cirrhosis
    • author reply 97
    • Comparcola D, Alisi A, Nobili V. Hepatitis C virus and nonalcoholic Fatty liver disease: similar risk factors for necroinflammation, fibrosis, and cirrhosis. Clinical Gastroenterology and Hepatology 2010; 8: 97; author reply 97.
    • (2010) Clinical Gastroenterology and Hepatology , vol.8 , pp. 97
    • Comparcola, D.1    Alisi, A.2    Nobili, V.3
  • 130
    • 0141682739 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome
    • Sanyal AJ, Contos MJ, Sterling RK, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. American J Gastroenterology 2003; 98: 2064-71.
    • (2003) American J Gastroenterology , vol.98 , pp. 2064-2071
    • Sanyal, A.J.1    Contos, M.J.2    Sterling, R.K.3
  • 131
    • 79959453427 scopus 로고    scopus 로고
    • Metabolic syndrome, chronic kidney disease, and cardiovascular disease: A dynamic and life-threatening triad
    • Raimundo M, Lopes JA. Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. Cardiol Res Pract 2011; 2011: 747861.
    • (2011) Cardiol Res Pract , vol.2011 , pp. 747861
    • Raimundo, M.1    Lopes, J.A.2
  • 132
    • 33748141662 scopus 로고    scopus 로고
    • Plasma aldosterone is independently associated with the metabolic syndrome
    • Bochud M, Nussberger J, Bovet P, et al. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension 2006; 48: 239-45.
    • (2006) Hypertension , vol.48 , pp. 239-245
    • Bochud, M.1    Nussberger, J.2    Bovet, P.3
  • 133
    • 33847048251 scopus 로고    scopus 로고
    • Association of adrenal steroids with hypertension and the metabolic syndrome in blacks
    • Kidambi S, Kotchen JM, Grim CE, et al. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension 2007; 49: 704-11.
    • (2007) Hypertension , vol.49 , pp. 704-711
    • Kidambi, S.1    Kotchen, J.M.2    Grim, C.E.3
  • 134
    • 34548419736 scopus 로고    scopus 로고
    • Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients
    • Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 2007; 30: 2349-54.
    • (2007) Diabetes Care , vol.30 , pp. 2349-2354
    • Colussi, G.1    Catena, C.2    Lapenna, R.3    Nadalini, E.4    Chiuch, A.5    Sechi, L.A.6
  • 135
    • 34548216220 scopus 로고    scopus 로고
    • Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome
    • Fujita T. Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome. J the Renin-Angiotensin-Aldosterone System 2006; 7: 181-3.
    • (2006) J the Renin-Angiotensin-Aldosterone System , vol.7 , pp. 181-183
    • Fujita, T.1
  • 136
    • 34547630857 scopus 로고    scopus 로고
    • Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Salt-Sensitive Hypertension
    • Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Salt-Sensitive Hypertension. Hypertension 2007; 50: 360-7.
    • (2007) Hypertension , vol.50 , pp. 360-367
    • Fujita, M.1    Ando, K.2    Nagae, A.3    Fujita, T.4
  • 137
    • 1242342716 scopus 로고    scopus 로고
    • Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure
    • Lindley TE, Doobay MF, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circulation Research 2004; 94: 402-9.
    • (2004) Circulation Research , vol.94 , pp. 402-409
    • Lindley, T.E.1    Doobay, M.F.2    Sharma, R.V.3    Davisson, R.L.4
  • 140
    • 33748157529 scopus 로고    scopus 로고
    • Protective effect of potassium against the hypertensive cardiac dysfunction: Association with reactive oxygen species reduction
    • Matsui H, Shimosawa T, Uetake Y, et al. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction. Hypertension 2006; 48: 225-31.
    • (2006) Hypertension , vol.48 , pp. 225-231
    • Matsui, H.1    Shimosawa, T.2    Uetake, Y.3
  • 141
    • 11844263385 scopus 로고    scopus 로고
    • High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex
    • Zhang X, Dong F, Ren J, Driscoll MJ, Culver B. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Experimental Neurology 2005; 191: 318-325.
    • (2005) Experimental Neurology , vol.191 , pp. 318-325
    • Zhang, X.1    Dong, F.2    Ren, J.3    Driscoll, M.J.4    Culver, B.5
  • 142
    • 0024323773 scopus 로고
    • The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents
    • Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. New England J Medicine 1989; 321: 580-5.
    • (1989) New England J Medicine , vol.321 , pp. 580-585
    • Rocchini, A.P.1    Key, J.2    Bondie, D.3
  • 143
    • 33746743021 scopus 로고    scopus 로고
    • Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension
    • Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertension 2006; 24: 1627-32.
    • (2006) J Hypertension , vol.24 , pp. 1627-1632
    • Uzu, T.1    Kimura, G.2    Yamauchi, A.3
  • 144
    • 0036318323 scopus 로고    scopus 로고
    • High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats
    • Ogihara T, Asano T, Ando K, et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 2002; 40: 83-9.
    • (2002) Hypertension , vol.40 , pp. 83-89
    • Ogihara, T.1    Asano, T.2    Ando, K.3
  • 146
    • 4544378858 scopus 로고    scopus 로고
    • Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits
    • Shukla N, Thompson CS, Angelini GD, Mikhailidis DP, Jeremy JY. Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits. Metabolism: Clinical and Experimental 2004; 53: 1315-21.
    • (2004) Metabolism: Clinical and Experimental , vol.53 , pp. 1315-1321
    • Shukla, N.1    Thompson, C.S.2    Angelini, G.D.3    Mikhailidis, D.P.4    Jeremy, J.Y.5
  • 147
    • 0034640107 scopus 로고    scopus 로고
    • Vascular superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors
    • Guzik TJ, West NE, Black E, et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circulation Research 2000; 86: E85-90.
    • (2000) Circulation Research , vol.86
    • Guzik, T.J.1    West, N.E.2    Black, E.3
  • 148
    • 25144453937 scopus 로고    scopus 로고
    • NADPH oxidase and endothelial cell function
    • Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clinical Science 2005; 109: 217-226.
    • (2005) Clinical Science , vol.109 , pp. 217-226
    • Ray, R.1    Shah, A.M.2
  • 149
    • 0037399439 scopus 로고    scopus 로고
    • Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
    • Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clinical Investigation 2003; 111: 1201-9.
    • (2003) J Clinical Investigation , vol.111 , pp. 1201-1209
    • Landmesser, U.1    Dikalov, S.2    Price, S.R.3
  • 151
    • 4444268721 scopus 로고    scopus 로고
    • Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension
    • Saez GT, Tormos C, Giner V, Chaves J, Lozano JV, Iradi A, Redon J. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. American J Hypertension 2004; 17: 809-16.
    • (2004) American J Hypertension , vol.17 , pp. 809-816
    • Saez, G.T.1    Tormos, C.2    Giner, V.3    Chaves, J.4    Lozano, J.V.5    Iradi, A.6    Redon, J.7
  • 154
    • 0035834028 scopus 로고    scopus 로고
    • Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: Antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy
    • Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 2001; 104: 1767-72.
    • (2001) Circulation , vol.104 , pp. 1767-1772
    • Rueckschloss, U.1    Galle, J.2    Holtz, J.3    Zerkowski, H.R.4    Morawietz, H.5
  • 155
    • 0033586639 scopus 로고    scopus 로고
    • Increased NADHoxidase - mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system
    • Warnholtz A, Nickenig G, Schulz E, et al. Increased NADHoxidase- mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999; 99: 2027-33.
    • (1999) Circulation , vol.99 , pp. 2027-2033
    • Warnholtz, A.1    Nickenig, G.2    Schulz, E.3
  • 156
    • 0036186652 scopus 로고    scopus 로고
    • Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians
    • Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002; 161: 233-42.
    • (2002) Atherosclerosis , vol.161 , pp. 233-242
    • Weyer, C.1    Yudkin, J.S.2    Stehouwer, C.D.3    Schalkwijk, C.G.4    Pratley, R.E.5    Tataranni, P.A.6
  • 157
    • 34347350171 scopus 로고    scopus 로고
    • Chronic kidney disease: Effects on the cardiovascular system
    • Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97.
    • (2007) Circulation , vol.116 , pp. 85-97
    • Schiffrin, E.L.1    Lipman, M.L.2    Mann, J.F.3
  • 159
    • 33749623475 scopus 로고    scopus 로고
    • Oxidative stress and atherosclerosis in early chronic kidney disease
    • Zalba G, Fortuno A, Diez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrology Dialysis Transplantation 2006; 21: 2686-90.
    • (2006) Nephrology Dialysis Transplantation , vol.21 , pp. 2686-2690
    • Zalba, G.1    Fortuno, A.2    Diez, J.3
  • 160
    • 76749150027 scopus 로고    scopus 로고
    • Vascular disease and chronic renal failure: New insights
    • Nanayakkara PW, Gaillard CA. Vascular disease and chronic renal failure: new insights. Netherlands J Medicine 2010; 68: 5-14.
    • (2010) Netherlands J Medicine , vol.68 , pp. 5-14
    • Nanayakkara, P.W.1    Gaillard, C.A.2
  • 161
    • 33947305508 scopus 로고    scopus 로고
    • Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure
    • Baber U, Toto RD, de Lemos JA. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure. American Heart Journal 2007; 153: 471-7.
    • (2007) American Heart Journal , vol.153 , pp. 471-477
    • Baber, U.1    Toto, R.D.2    de Lemos, J.A.3
  • 162
    • 33751009384 scopus 로고    scopus 로고
    • Oxidative stress is progressively enhanced with advancing stages of CKD
    • Dounousi E, Papavasiliou E, Makedou A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. American J Kidney Diseases 2006; 48: 752-60.
    • (2006) American J Kidney Diseases , vol.48 , pp. 752-760
    • Dounousi, E.1    Papavasiliou, E.2    Makedou, A.3
  • 163
    • 27744608003 scopus 로고    scopus 로고
    • Essential hypertension, progressive renal disease, and uric acid: A pathogenetic link?
    • Johnson RJ, Segal MS, Srinivas T, et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J the American Society of Nephrology 2005; 16: 1909-19.
    • (2005) J the American Society of Nephrology , vol.16 , pp. 1909-1919
    • Johnson, R.J.1    Segal, M.S.2    Srinivas, T.3
  • 164
    • 0031093278 scopus 로고    scopus 로고
    • Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors
    • Becker BN, Himmelfarb J, Henrich WL, Hakim RM. Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J the American Society of Nephrology 1997; 8: 475-86.
    • (1997) J the American Society of Nephrology , vol.8 , pp. 475-486
    • Becker, B.N.1    Himmelfarb, J.2    Henrich, W.L.3    Hakim, R.M.4
  • 165
    • 0033854483 scopus 로고    scopus 로고
    • Increased intracellular reactive oxygen species in patients with end-stage renal failure: Effect of hemodialysis
    • Tepel M, Echelmeyer M, Orie NN, Zidek W. Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of hemodialysis. Kidney International 2000; 58: 867-72.
    • (2000) Kidney International , vol.58 , pp. 867-872
    • Tepel, M.1    Echelmeyer, M.2    Orie, N.N.3    Zidek, W.4
  • 167
    • 21644436782 scopus 로고    scopus 로고
    • Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin
    • Terawaki H, Yoshimura K, Hasegawa T, et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney International 2004; 66: 1988-93.
    • (2004) Kidney International , vol.66 , pp. 1988-1993
    • Terawaki, H.1    Yoshimura, K.2    Hasegawa, T.3
  • 168
    • 18844471606 scopus 로고    scopus 로고
    • Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure
    • Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunology 1998; 161: 2524-32.
    • (1998) J Immunology , vol.161 , pp. 2524-2532
    • Witko-Sarsat, V.1    Friedlander, M.2    Nguyen Khoa, T.3
  • 169
    • 77449122756 scopus 로고    scopus 로고
    • Oxidative stress in renal dysfunction: Mechanisms, clinical sequelae and therapeutic options
    • Kao MP, Ang DS, Pall A, Struthers AD. Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options. J Human Hypertension 2010; 24: 1-8.
    • (2010) J Human Hypertension , vol.24 , pp. 1-8
    • Kao, M.P.1    Ang, D.S.2    Pall, A.3    Struthers, A.D.4
  • 171
    • 0029086172 scopus 로고
    • Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure
    • Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clinical Chemistry 1995; 41: 1135-8.
    • (1995) Clinical Chemistry , vol.41 , pp. 1135-1138
    • Jackson, P.1    Loughrey, C.M.2    Lightbody, J.H.3    McNamee, P.T.4    Young, I.S.5
  • 172
    • 0028265472 scopus 로고
    • Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron status
    • Peuchant E, Carbonneau MA, Dubourg L, et al. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status. Free Radical Biology & Medicine 1994; 16: 339-46.
    • (1994) Free Radical Biology & Medicine , vol.16 , pp. 339-346
    • Peuchant, E.1    Carbonneau, M.A.2    Dubourg, L.3
  • 173
    • 34547185623 scopus 로고    scopus 로고
    • Oxidative stress and redox signalling in cardiac hypertrophy and heart failure
    • Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007; 93: 903-7.
    • (2007) Heart , vol.93 , pp. 903-907
    • Seddon, M.1    Looi, Y.H.2    Shah, A.M.3
  • 174
  • 175
    • 77952423444 scopus 로고    scopus 로고
    • Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension
    • de la Sierra A, Larrousse M. Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension. J Human Hypertension 2010; 24: 373-379.
    • (2010) J Human Hypertension , vol.24 , pp. 373-379
    • de la Sierra, A.1    Larrousse, M.2
  • 176
    • 25644452089 scopus 로고    scopus 로고
    • Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes
    • Farvid MS, Jalali M, Siassi F, Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 2005; 28: 2458-64.
    • (2005) Diabetes Care , vol.28 , pp. 2458-2464
    • Farvid, M.S.1    Jalali, M.2    Siassi, F.3    Hosseini, M.4
  • 178
    • 0026755677 scopus 로고
    • Effect of dietary supplementation with alphatocopherol on the oxidative modification of low density lipoprotein
    • Jialal I, Grundy SM. Effect of dietary supplementation with alphatocopherol on the oxidative modification of low density lipoprotein. J Lipid Research 1992; 33: 899-906.
    • (1992) J Lipid Research , vol.33 , pp. 899-906
    • Jialal, I.1    Grundy, S.M.2
  • 180
    • 0034126755 scopus 로고    scopus 로고
    • Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
    • Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatrics 2000; 136: 734-8.
    • (2000) J Pediatrics , vol.136 , pp. 734-738
    • Lavine, J.E.1
  • 181
    • 0024260831 scopus 로고
    • Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Doubleblind crossover trial
    • Gisinger C, Jeremy J, Speiser P, Mikhailidis D, Dandona P, Schernthaner G. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Doubleblind crossover trial. Diabetes 1988; 37: 1260-4.
    • (1988) Diabetes , vol.37 , pp. 1260-1264
    • Gisinger, C.1    Jeremy, J.2    Speiser, P.3    Mikhailidis, D.4    Dandona, P.5    Schernthaner, G.6
  • 182
    • 59849084406 scopus 로고    scopus 로고
    • Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes
    • Haidara MA, Mikhailidis DP, Rateb MA, et al. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes. J Diabetes and Its Complications 2009; 23: 130-6.
    • (2009) J Diabetes and Its Complications , vol.23 , pp. 130-136
    • Haidara, M.A.1    Mikhailidis, D.P.2    Rateb, M.A.3
  • 183
    • 45149111073 scopus 로고    scopus 로고
    • Severe liver steatosis correlates with nitrosative and oxidative stress in rats
    • Grattagliano I, Caraceni P, Calamita G, et al. Severe liver steatosis correlates with nitrosative and oxidative stress in rats. European J Clinical Investigation 2008; 38: 523-30.
    • (2008) European J Clinical Investigation , vol.38 , pp. 523-530
    • Grattagliano, I.1    Caraceni, P.2    Calamita, G.3
  • 184
    • 20044366744 scopus 로고    scopus 로고
    • Ascorbic acid selectively improves large elastic artery compliance in postmenopausal women
    • Moreau KL, Gavin KM, Plum AE, Seals DR. Ascorbic acid selectively improves large elastic artery compliance in postmenopausal women. Hypertension 2005; 45: 1107-12.
    • (2005) Hypertension , vol.45 , pp. 1107-1112
    • Moreau, K.L.1    Gavin, K.M.2    Plum, A.E.3    Seals, D.R.4
  • 185
    • 0030940959 scopus 로고    scopus 로고
    • Fruit and vegetables, and cardiovascular disease: A review
    • Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. International J Epidemiology 1997; 26: 1-13.
    • (1997) International J Epidemiology , vol.26 , pp. 1-13
    • Ness, A.R.1    Powles, J.W.2
  • 186
    • 31444443311 scopus 로고    scopus 로고
    • Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies
    • He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006; 367: 320-6.
    • (2006) Lancet , vol.367 , pp. 320-326
    • He, F.J.1    Nowson, C.A.2    Macgregor, G.A.3
  • 187
    • 0037840165 scopus 로고    scopus 로고
    • Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials
    • Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361: 2017-23.
    • (2003) Lancet , vol.361 , pp. 2017-2023
    • Vivekananthan, D.P.1    Penn, M.S.2    Sapp, S.K.3    Hsu, A.4    Topol, E.J.5
  • 188
    • 33845336554 scopus 로고    scopus 로고
    • Randomized placebocontrolled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis
    • Dufour JF, Oneta CM, Gonvers JJ, et al. Randomized placebocontrolled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clinical Gastroenterology and Hepatology 2006; 4: 1537-43.
    • (2006) Clinical Gastroenterology and Hepatology , vol.4 , pp. 1537-1543
    • Dufour, J.F.1    Oneta, C.M.2    Gonvers, J.J.3
  • 189
    • 0344742265 scopus 로고    scopus 로고
    • Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
    • Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. American J Gastroenterology 2003; 98: 2485-90.
    • (2003) American J Gastroenterology , vol.98 , pp. 2485-2490
    • Harrison, S.A.1    Torgerson, S.2    Hayashi, P.3    Ward, J.4    Schenker, S.5
  • 190
    • 77951874018 scopus 로고    scopus 로고
    • Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
    • Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. New England J Medicine 2010; 362: 1675-85.
    • (2010) New England J Medicine , vol.362 , pp. 1675-1685
    • Sanyal, A.J.1    Chalasani, N.2    Kowdley, K.V.3
  • 191
    • 55149106587 scopus 로고    scopus 로고
    • Nutritional supplementation for type 2 diabetes: A systematic review
    • Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic and Physiological Optics 2008; 28: 503-23.
    • (2008) Ophthalmic and Physiological Optics , vol.28 , pp. 503-523
    • Bartlett, H.E.1    Eperjesi, F.2
  • 193
    • 33644807156 scopus 로고    scopus 로고
    • High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance
    • Chen H, Karne RJ, Hall G, et al. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. American J Physiology - Heart and Circulatory Physiology 2006; 290: H137-45.
    • (2006) American J Physiology - Heart and Circulatory Physiology , vol.290
    • Chen, H.1    Karne, R.J.2    Hall, G.3
  • 194
    • 34948814624 scopus 로고    scopus 로고
    • The relationship between dose of vitamin E and suppression of oxidative stress in humans
    • Roberts LJ, 2nd, Oates JA, Linton MF, et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radical Biology & Medicine 2007; 43: 1388-93.
    • (2007) Free Radical Biology & Medicine , vol.43 , pp. 1388-1393
    • Roberts 2nd, L.J.1    Oates, J.A.2    Linton, M.F.3
  • 195
    • 34447128568 scopus 로고    scopus 로고
    • Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes
    • Hartweg J, Farmer AJ, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 2007; 50: 250-8.
    • (2007) Diabetologia , vol.50 , pp. 250-258
    • Hartweg, J.1    Farmer, A.J.2    Holman, R.R.3    Neil, H.A.4
  • 197
    • 54949103935 scopus 로고    scopus 로고
    • Alpha-lipoic acid supplementation and diabetes
    • Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutrition Reviews 2008; 66: 646-57.
    • (2008) Nutrition Reviews , vol.66 , pp. 646-657
    • Singh, U.1    Jialal, I.2
  • 198
  • 199
    • 47149113157 scopus 로고    scopus 로고
    • Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes
    • Lau FC, Bagchi M, Sen CK, Bagchi D. Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes. Molecular and Cellular Biochemistry 2008; 317: 1-10.
    • (2008) Molecular and Cellular Biochemistry , vol.317 , pp. 1-10
    • Lau, F.C.1    Bagchi, M.2    Sen, C.K.3    Bagchi, D.4
  • 200
    • 7944231021 scopus 로고    scopus 로고
    • Nutraceutical resources for diabetes prevention-an update
    • McCarty MF. Nutraceutical resources for diabetes prevention-an update. Medical Hypotheses 2005; 64: 151-8.
    • (2005) Medical Hypotheses , vol.64 , pp. 151-158
    • McCarty, M.F.1
  • 201
    • 67949094377 scopus 로고    scopus 로고
    • Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults
    • Czernichow S, Vergnaud AC, Galan P, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. American J Clinical Nutrition 2009; 90: 329-35.
    • (2009) American J Clinical Nutrition , vol.90 , pp. 329-335
    • Czernichow, S.1    Vergnaud, A.C.2    Galan, P.3
  • 202
    • 0034254961 scopus 로고    scopus 로고
    • Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers
    • Patrignani P, Panara MR, Tacconelli S, et al. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation 2000; 102: 539-45.
    • (2000) Circulation , vol.102 , pp. 539-545
    • Patrignani, P.1    Panara, M.R.2    Tacconelli, S.3
  • 203
    • 77954371707 scopus 로고    scopus 로고
    • Nutraceuticals in diabetes and metabolic syndrome
    • Davi G, Santilli F, Patrono C. Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 2010; 28: 216-26.
    • (2010) Cardiovasc Ther , vol.28 , pp. 216-226
    • Davi, G.1    Santilli, F.2    Patrono, C.3
  • 204
    • 34547733397 scopus 로고    scopus 로고
    • Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidasemediated oxidative/nitrosative stress
    • Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidasemediated oxidative/nitrosative stress. American J Physiology - Cell Physiology 2007; 293: C584-C596.
    • (2007) American J Physiology - Cell Physiology , vol.293
    • Sautin, Y.Y.1    Nakagawa, T.2    Zharikov, S.3    Johnson, R.J.4
  • 205
    • 34547733397 scopus 로고    scopus 로고
    • Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidasemediated oxidative/nitrosative stress
    • Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidasemediated oxidative/nitrosative stress. American J Physiology - Cell Physiology 2007; 293: C584-96.
    • (2007) American J Physiology - Cell Physiology , vol.293
    • Sautin, Y.Y.1    Nakagawa, T.2    Zharikov, S.3    Johnson, R.J.4
  • 207
  • 209
  • 211
    • 33750431077 scopus 로고    scopus 로고
    • Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders
    • Griffin JL, Nicholls AW. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics 2006; 7: 1095-107.
    • (2006) Pharmacogenomics , vol.7 , pp. 1095-1107
    • Griffin, J.L.1    Nicholls, A.W.2
  • 212
    • 0041326831 scopus 로고    scopus 로고
    • Effects of age and caloric restriction on glutathione redox state in mice
    • Rebrin I, Kamzalov S, Sohal RS. Effects of age and caloric restriction on glutathione redox state in mice. Free Radical Biology & Medicine 2003; 35: 626-35.
    • (2003) Free Radical Biology & Medicine , vol.35 , pp. 626-635
    • Rebrin, I.1    Kamzalov, S.2    Sohal, R.S.3
  • 214
    • 0033954443 scopus 로고    scopus 로고
    • High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk
    • Abbasi F, McLaughlin T, Lamendola C, et al. High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk. American J Cardiology 2000; 85: 45-8.
    • (2000) American J Cardiology , vol.85 , pp. 45-48
    • Abbasi, F.1    McLaughlin, T.2    Lamendola, C.3
  • 215
    • 20444389800 scopus 로고    scopus 로고
    • Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: A randomized, crossover, controlled, clinical trial
    • Fito M, Cladellas M, de la Torre R, et al. Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis 2005; 181: 149-58.
    • (2005) Atherosclerosis , vol.181 , pp. 149-158
    • Fito, M.1    Cladellas, M.2    de la Torre, R.3
  • 216
    • 33847378451 scopus 로고    scopus 로고
    • Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and metaanalysis
    • Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. JAMA 2007; 297: 842-57.
    • (2007) JAMA , vol.297 , pp. 842-857
    • Bjelakovic, G.1    Nikolova, D.2    Gluud, L.L.3    Simonetti, R.G.4    Gluud, C.5
  • 217
    • 2442421194 scopus 로고    scopus 로고
    • Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited
    • Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosclerosis Thrombosis and Vascular Biology 2004; 24: 816-23.
    • (2004) Arteriosclerosis Thrombosis and Vascular Biology , vol.24 , pp. 816-823
    • Ceriello, A.1    Motz, E.2
  • 218
    • 0030048496 scopus 로고    scopus 로고
    • Oxidative stress and diabetic vascular complications
    • Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
    • (1996) Diabetes Care , vol.19 , pp. 257-267
    • Giugliano, D.1    Ceriello, A.2    Paolisso, G.3
  • 219
    • 59349121851 scopus 로고    scopus 로고
    • The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: What is the clinical relevance?
    • Rizzo M, Rizvi AA, Rini GB, Berneis K. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetologica 2009; 46: 1-11.
    • (2009) Acta Diabetologica , vol.46 , pp. 1-11
    • Rizzo, M.1    Rizvi, A.A.2    Rini, G.B.3    Berneis, K.4
  • 220
    • 34447135689 scopus 로고    scopus 로고
    • Metaanalysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes
    • Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA. Metaanalysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia 2007; 50: 1593-602.
    • (2007) Diabetologia , vol.50 , pp. 1593-1602
    • Hartweg, J.1    Farmer, A.J.2    Perera, R.3    Holman, R.R.4    Neil, H.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.